← back to search

Wei Xu

Hubei University of Medicine · CN
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Prohibitin and Cell biology, with related work in Adipogenesis, microRNA, Microvesicles. Notable publications include 'MicroRNA-27 (miR-27) Targets Prohibitin and Impairs Adipocyte Differentiation and Mitochondrial Function in Human Adipose-derived Stem Cells', 'Exosomes derived from endometriotic stromal cells have enhanced angiogenic effects in vitro', and 'Mitochondrial Dysfunction and Adipogenic Reduction by Prohibitin Silencing in 3T3-L1 Cells'.
h-index
citations
491
works
7
NIH funding
primary concept
email

Recent publications

TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis
Inflammation 2023cited by 22position: middledoi
Spatio-temporal model of Meox1 expression control involvement of Sca-1-positive stem cells in neointima formation through the synergistic effect of Rho/CDC42 and SDF-1α/CXCR4
Stem Cell Research & Therapy 2021cited by 8position: middledoi
C-Reactive Protein Causes Adult-Onset Obesity Through Chronic Inflammatory Mechanism
Frontiers in Cell and Developmental Biology 2020cited by 57position: middledoi
Exosomes derived from endometriotic stromal cells have enhanced angiogenic effects in vitro
Cell and Tissue Research 2016cited by 129position: middledoi
MicroRNA-27 (miR-27) Targets Prohibitin and Impairs Adipocyte Differentiation and Mitochondrial Function in Human Adipose-derived Stem Cells
Journal of Biological Chemistry 2013cited by 154position: middledoi
Prohibitin‐2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label‐free quantitative proteomics strategy
Molecular Carcinogenesis 2013cited by 46position: middledoi
Mitochondrial Dysfunction and Adipogenic Reduction by Prohibitin Silencing in 3T3-L1 Cells
PLoS ONE 2012cited by 75position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2012–2023)Ting Kang · Sichuan University2 papers (2012–2013) · 2 papers (2016–2023)Neil Sidell · Emory University2 papers (2016–2023)Minerva T. Garcia-Barrio · University of Michigan2 papers (2012–2016)Robert N. Taylor · University at Buffalo, State University of New York2 papers (2016–2023) · 2 papers (2016–2023)Jin Zou · Nanchang University1 papers (2020–2020)Yiming Lin · Fujian Medical University1 papers (2012–2012)Bo Huang · Chongqing University1 papers (2012–2012)Lin Zhou · Fudan University1 papers (2013–2013)Yan Wu · Central South University1 papers (2021–2021)Shi‐You Chen · Georgetown University1 papers (2021–2021)Yangyang Deng · Virginia Commonwealth University1 papers (2020–2020)Xingyuan Li · Jiangsu University1 papers (2021–2021)Lanbo Zhao · Xi'an Jiaotong University1 papers (2020–2020) · 1 papers (2020–2020)Qing Song · Nanjing University of Chinese Medicine1 papers (2020–2020)Xin Bao · Hubei University of Medicine1 papers (2021–2021)Jun-mingTang · Hubei University of Medicine1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →